Effectiveness of an Inactivated SARS-CoV-2 Vaccine

In a national prospective cohort study involving 10.2 million participants in Chile, the effectiveness of an inactivated SARS-CoV-2 vaccine, which had been developed in China and administered in two doses 28 days apart, was estimated. Effectiveness among fully immunized persons was estimated at 65.9% for Covid-19 and at 87.5% for hospitalization, 90.3% for ICU admission, and 86.3% for death.

https://www.nejm.org/do/10.1056/NEJMdo006192/full/?fbclid=IwAR07laG7Xx0za9-ITdkrdfyKfBNdcrYDPqurK0eHKywMWVij7LkfDW7HH6I

Créditos: Comité científico Covid